Accounting for approximately 20% of all cases, triple negative breast cancer (TNBC) is characterized by tumors lacking epidermal growth factor receptor 2 (HER2), estrogen receptor (ER) and progesterone receptor (PR) [2]. Here, PGR is linked to triple-negative breast carcinoma.